BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

8054 related articles for article (PubMed ID: 2195120)

  • 1. Detection of urinary TGF-alpha by HPLC and western blot in patients with melanoma.
    Ellis DL; Chow JC; King LE
    J Invest Dermatol; 1990 Jul; 95(1):27-30. PubMed ID: 2195120
    [TBL] [Abstract][Full Text] [Related]  

  • 2. High molecular weight type-alpha transforming growth factor in the urine of patients with surgical bone wound involved in mandibular osteotomy.
    Aladib W; Yoshida H; Sato M
    Bone Miner; 1990 Apr; 9(1):59-70. PubMed ID: 2337689
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Distinct high-performance liquid chromatography pattern of transforming growth factor activity in urine of cancer patients as compared with that of normal individuals.
    Kimball ES; Bohn WH; Cockley KD; Warren TC; Sherwin SA
    Cancer Res; 1984 Aug; 44(8):3613-9. PubMed ID: 6331653
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Urinary transforming growth factors in neoplasia: separation of 125I-labeled transforming growth factor-alpha from epidermal growth factor in human urine.
    Stromberg K; Hudgins WR
    Cancer Res; 1986 Nov; 46(11):6004-10. PubMed ID: 3019543
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Detection of transforming growth factor alpha in human urine and plasma.
    Katoh M; Inagaki H; Kurosawa-Ohsawa K; Katsuura M; Tanaka S
    Biochem Biophys Res Commun; 1990 Mar; 167(3):1065-72. PubMed ID: 2157422
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Epidermal and transforming growth factor alpha in patients with breast tumours.
    Gregory H; Thomas CE; Willshire IR; Young JA; Anderson H; Baildam A; Howell A
    Br J Cancer; 1989 Apr; 59(4):605-9. PubMed ID: 2785399
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Urinary excretion of epidermal-type fatty acid-binding protein and S100A7 protein in patients with cutaneous melanoma.
    Brouard MC; Saurat JH; Ghanem G; Siegenthaler G
    Melanoma Res; 2002 Dec; 12(6):627-31. PubMed ID: 12459653
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Transforming growth factor type beta in normal human urine.
    Ranganathan G; Lyons R; Jiang NS; Moses H
    Biochem Biophys Res Commun; 1987 Nov; 148(3):1503-12. PubMed ID: 3318836
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Measurement of eumelanin precursor metabolites in the urine as a new marker for melanoma metastases.
    Yamada K; Walsh N; Hara H; Jimbow K; Chen H; Ito S
    Arch Dermatol; 1992 Apr; 128(4):491-4. PubMed ID: 1580656
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Production of transforming growth factor-alpha in human tumour cell lines.
    Imanishi K; Yamaguchi K; Suzuki M; Honda S; Yanaihara N; Abe K
    Br J Cancer; 1989 May; 59(5):761-5. PubMed ID: 2736210
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Identification of ester glucuronide and sulfate conjugates of 5-hydroxy-6-methoxyindole-2-carboxylic acid and 6-hydroxy-5-methoxyindole-2-carboxylic acid in melanoma urine.
    Wakamatsu K; Ito S
    J Dermatol Sci; 1990 Jul; 1(4):253-9. PubMed ID: 2095194
    [TBL] [Abstract][Full Text] [Related]  

  • 12. In situ analysis of transforming growth factor-beta s (TGF-beta 1, TGF-beta 2, TGF-beta 3), and TGF-beta type II receptor expression in malignant melanoma.
    Schmid P; Itin P; Rufli T
    Carcinogenesis; 1995 Jul; 16(7):1499-503. PubMed ID: 7614683
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Determination of eumelanin in human urine.
    Wakamatsu K; Takasaki A; Kågedal B; Kageshita T; Ito S
    Pigment Cell Res; 2006 Apr; 19(2):163-9. PubMed ID: 16524432
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Melanoma-associated expression of transforming growth factor-beta isoforms.
    Van Belle P; Rodeck U; Nuamah I; Halpern AC; Elder DE
    Am J Pathol; 1996 Jun; 148(6):1887-94. PubMed ID: 8669474
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Characterization of high molecular weight transforming growth factor alpha produced by rat hepatocellular carcinoma cells.
    Luetteke NC; Michalopoulos GK; Teixidó J; Gilmore R; Massagué J; Lee DC
    Biochemistry; 1988 Aug; 27(17):6487-94. PubMed ID: 3219349
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Trichochromes in the urine of melanoma patients.
    Agrup G; Lindbladh C; Prota G; Rorsman H; Rosengren AM; Rosengren E
    J Invest Dermatol; 1978 Feb; 70(2):90-1. PubMed ID: 621413
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Malignant melanoma in neo-bladder urinary cytology: a brief report.
    Sathiyamoorthy S; Ali SZ
    Diagn Cytopathol; 2013 Nov; 41(11):997-9. PubMed ID: 22730159
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Comparison of urinary transforming growth factor-alpha in women with disseminated breast cancer and healthy control women.
    Stromberg K; Duffy M; Fritsch C; Hudgins WR; Sharp ES; Murphy LD; Lippman ME; Bates SE
    Cancer Detect Prev; 1991; 15(4):277-83. PubMed ID: 1794134
    [TBL] [Abstract][Full Text] [Related]  

  • 19. UVR induction of TGF alpha: a possible autocrine mechanism for the epidermal melanocytic response and for promotion of epidermal carcinogenesis.
    Ellem KA; Cullinan M; Baumann KC; Dunstan A
    Carcinogenesis; 1988 May; 9(5):797-801. PubMed ID: 3163273
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Immunoreactive alpha transforming growth factor activity in effusions from cancer patients as a marker of tumor burden and patient prognosis.
    Arteaga CL; Hanauske AR; Clark GM; Osborne CK; Hazarika P; Pardue RL; Tio F; Von Hoff DD
    Cancer Res; 1988 Sep; 48(17):5023-8. PubMed ID: 3165707
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 403.